Hungary’s medical devices sector, dominated by innovative SMEs, is a key player in Europe’s MedTech industry, exporting 85% of its production, primarily to the EU. The competitiveness strategy aims to boost domestic production and sustainability while navigating EU MDR challenges. Opportunities for collaboration with Hong Kong include leveraging trade networks, regulatory expertise, and investment to enhance global market access and innovation.

In order to promote the integration of technological and industrial innovation in the field of biomedicine and to accelerate the development, industrialisation and application of innovative drugs and medical devices, Guangdong’s Department of Industry and Information Technology, Health Commission, Healthcare Security Administration and Medical Products Administration have jointly issued a first-batch catalogue of innovative drugs and medical devices approved in the province, in accordance with the Action Plan on Further Promoting the High-Quality Development of Guangdong’s Biopharmaceutical Industry.

Including statistics of Medicine and Medical Device Sales of China in the past 6 years.

On 1 July, the National Healthcare Security Administration and the National Health Commission jointly announced multiple measures to support the high-quality development of innovative drugs. Priority is to be given to supporting innovative drug research and development (R&D), the inclusion of new drugs in insurance drug catalogues and their use in clinical application, diversifying payment channels for innovative drugs, and more.